Byeong‐Cheol Ahn
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
-
- Thyroid Cancer Diagnosis and Treatment
Papers in
-
- Extracellular vesicles in disease 38
- RNA Interference and Gene Delivery 17
-
- Thyroid Cancer Diagnosis and Treatment 53
- Co-authors
- Prakash Gangadaran (101 shared papers)Jaetae Lee (155 shared papers)Shin Young Jeong (96 shared papers)Ji Min Oh (43 shared papers)Chae Moon Hong (71 shared papers)Sang‐Woo Lee (86 shared papers)S Kalimuthu (24 shared papers)Ramya Lakshmi Rajendran (70 shared papers)
- Journals
- Scientific Reports (10 papers)Thyroid (9 papers)PLoS ONE (7 papers)Nuclear Medicine Communications (6 papers)Experimental Cell Research (5 papers)
- Partner nations
- South KoreaIndiaUnited States
In The Last Decade
Byeong‐Cheol Ahn
260 papers receiving 6.7k citations
Byeong‐Cheol Ahn's Hit Papers
Peers
Comparison fields: 5 of 148
- Cancer Research 1.1k
- Endocrinology, Diabetes and Metabolism 940
- Urology 307
- Genetics 417
- Molecular Biology 2.7k
Countries citing papers authored by Byeong‐Cheol Ahn
This map shows the geographic impact of Byeong‐Cheol Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byeong‐Cheol Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byeong‐Cheol Ahn more than expected).
Fields of papers citing papers by Byeong‐Cheol Ahn
This network shows the impact of papers produced by Byeong‐Cheol Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byeong‐Cheol Ahn. The network helps show where Byeong‐Cheol Ahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Byeong‐Cheol Ahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 274 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 400 | |
| 2 | 2018 | 234 | |
| 3 | Tumor microenvironment signaling and therapeutics in cancer progression Hit paper breakdown → | 2023 | 183 |
| 4 | 2021 | 172 | |
| 5 | 2017 | 147 | |
| 6 | 2014 | 134 | |
| 7 | 2022 | 132 | |
| 8 | 2018 | 123 | |
| 9 | 2018 | 123 | |
| 10 | 2012 | 116 | |
| 11 | False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer. | 2012 | 104 |
| 12 | 2021 | 101 | |
| 13 | 2012 | 100 | |
| 14 | 2020 | 99 | |
| 15 | 2018 | 99 | |
| 16 | 2019 | 95 | |
| 17 | 2017 | 93 | |
| 18 | 2017 | 90 | |
| 19 | 2022 | 88 | |
| 20 | 2018 | 83 |
About Byeong‐Cheol Ahn
Byeong‐Cheol Ahn is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Oncology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 274 papers that have together received 6.8k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (53 papers), Extracellular vesicles in disease (38 papers), RNA Interference and Gene Delivery (17 papers), Mesenchymal stem cell research (16 papers), Medical Imaging Techniques and Applications (15 papers), MicroRNA in disease regulation (14 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Immunotherapy and Immune Responses (12 papers). The work is most often cited by research in Cancer Research (1.1k citations), Endocrinology, Diabetes and Metabolism (940 citations), Urology (307 citations), Genetics (417 citations) and Molecular Biology (2.7k citations). Byeong‐Cheol Ahn has collaborated with scholars based in South Korea, India and United States. Frequent co-authors include Prakash Gangadaran, Jaetae Lee, Shin Young Jeong, Ji Min Oh, Chae Moon Hong, Sang‐Woo Lee, S Kalimuthu, Ramya Lakshmi Rajendran, Ho‐Won Lee and Liya Zhu. Their work appears in journals such as Scientific Reports, Thyroid, PLoS ONE, Nuclear Medicine Communications and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.